The Procter & Gamble Company

Rhodia Limited

Other

Milliken & Company

The Proctor & Gamble Co.

Basf Se Corporation

Wacker Chemie Ag

Nutrition & Biosciences USA 4, Inc.

Solvay USA Inc.

Strike Investments, LLC

The Cleveland Clinic Foundation

The Procter & Gamble

Mark Robert Sivik

William Michael Scheper

Bernard William Kluesener

Frank William Denome

Gregory Charles Gordon

Frederick Anthony Hartman

Paul Thomas Weisman

Paul Dennis Trokhan

John Cort Severns

Nicholas David Vetter

Andreas Josef Dreher

Rajan Keshav Panandiker

Travis Kyle Hodgdon

Jean-Francois Bodet

Kevin Lee Kott

Aaron Flores-Figueroa

Gregory Scot Miracle

Alessandro Corona, Iii

Robert Richard Dykstra

Keith Homer Baker

Toan Trinh

Eduardo Torres

Dominick Joseph Valenti

Patrick D Moore

Errol Hoffman Wahl

Eugene Steven Sadlowski

Renae Dianna Fossum

Richard Timothy Hartshorn

Robb Richard Gardner

Reinhold J Leyrer

Gayle Marie Frankenbach

Mark William Hamersky

Janet Sue Littig

Marc Johan Declercq

Hugo Jean Marie Demeyere

Stephen Robert Glassmeyer

Robert Wayne Glenn, Jr

Ellen Schmidt Baker

Chandrika Kasturi

Brian Joseph Loughnane

Susanne Birkel

Jeffrey John Scheibel

Eugene Paul Gosselink

Alan David Willey

Stephen Wayne Heinzman

John Christian Haught

Weiming Qiu

Mark Ryan Richards

Phillip Kyle Vinson

Daniel Stedman Connor

John Michael Gardlik

Thomas Anthony Cripe

James Charles Theophile Roger Burckett-St Laurent

Alrick Vincent Warner

Ming Tang

Jeffrey Scott Dupont

Christian Bittner

Michael E Burns

Ludwig Voelkel

Jennifer Mary Marsh

Frank Dietsche

Arseni Valerevich Radomyselski

Alex Haejoon Chung

Dieter Hannu Boeckh

Helen S M Lu

Xiaoyong Hong

Johan Smets

Stefano Scialla

Neil Joseph Lant

Qi Zhang

Jean-Luc Philippe Bettiol

Eric Scott Johnson

Corey James Kenneally

Karel Jozef Maria Depoot

Andre Cesar Baeck

Kerry Andrew Vetter

Sherri Lynn Randall

Helen Bernardo Tordil

Howard David Hutton, Iii

Patti Jean Kellett

Hiroshi Oh

Jean-Pol Boutique

Philip Frank Souter

Stanley Leon Hazen

Brian Joseph Roselle

Patrick Firmin August Delplancke

Jayme L Paullin

Ekkehard Jahns

Volker Schwendemann

Kenneth Nathan Price

Yonas Gizaw

Peter Robert Foley

Christopher Mark Perkins

Dennis Ray Bacon

Matthew Lawrence Lynch

Christian Priou

Rakesh Nambiar

Karl Ghislain Braeckman

Steven Ray Gilbert

Frederick E Hardy

Natural polymer-based fibrous elements including a modified polymer derived from a natural polymer and a surfactant, method for making such natural polymer-based fibrous elements and methods for making such fibrous structures are provided.

Natural polymer-based fibrous elements comprising a surfactant and methods for making same

Treatment compositions, such as fabric care or dish care compositions, that include poly alpha-1,6-glucan ether compounds, which include poly alpha-1,6-glucans substituted with at least one positively charged organic group, the compounds being characterized by, for example, a degree of substitution of about 0.001 to about 3.0, and optionally, where about 3% or more of the backbone glucose monomer units have branches via alpha-1,2- and/or alpha-1,3-glycosidic linkages. Methods related to making and using such compositions.

Treatment compositions comprising cationic poly alpha-6,6-glucan ethers

Pouches, for example pouches that contain one or more active agents, such as a fabric care active agent or dishwashing active agent and/or detergent compositions, and more particularly pouches employing a water-soluble fibrous wall material, pouches employing a fibrous wall material that ruptures during use, and methods for making same, are provided.

Pouches comprising water-soluble fibrous wall materials and methods for making same

Described herein is a water-soluble unit dose with a particle having a ratio of Linear Alkylbenzene Sulfonate to Alkylethoxylated Sulfate of greater than 1.

Water-soluble unit dose articles comprising water-soluble fibrous structures and particles

The present invention relates to treatment compositions containing polymer systems that provide stability and benefit agent deposition as well as methods of making and using same. Such treatment compositions may be used for example as through the wash and/or through the rinse fabric enhancers as well as unit dose treatment compositions.

Treatment compositions

A process for manufacturing a water soluble product including the steps of: providing a water soluble fibrous first ply; providing a water soluble fibrous second ply formed on a surface other than the first ply, wherein the second ply is separate from the first ply; superposing the first ply and the second ply; and joining a first portion of the first ply to a second portion of the second ply to form the water soluble product.

Process of making a multi-ply fibrous water soluble product

A detergent product containing a detergent composition is provided.

Detergent product and method for making same

Described herein is a method for making fibrous water-soluble unit doses utilizing a repeating nested pattern.

Method of manufacturing water-soluble unit dose articles comprising water-soluble fibrous structures

Active agent-containing articles, for example fibrous structures, that exhibit consumer acceptable article in-use properties, such as article peel strength, flexibility, and/or dissolvability, and methods for making same are provided.

Active agent-containing articles that exhibit consumer acceptable article in-use properties

Active agent-containing articles, for example fibrous structures, that exhibit consumer acceptable article in-use properties, such as flexibility, article dimensions, and/or dissolvability, and product-shipping assemblies for containing the same are provided.

Active agent-containing articles and product-shipping assemblies for containing the same

Active agent-containing articles, for example fibrous structures, that exhibit consumer acceptable article in-use properties, such as article peel strength, flexibility, article dimensions, and/or dissolvability, and methods for making same are provided.

A method of making a non-fibrous laundry detergent sheet can include dispensing a microcapsule onto a precursor non-fibrous laundry detergent sheet, wherein the precursor non-fibrous laundry detergent sheet can include: (a) at least one surfactant; (b) at least one film former; and (c) a thickness ranging from 0.1 mm to 10 mm.

Laundry detergent sheet with microcapsules

Fibrous structures containing one or more particles, and methods for making same are provided.

Fibrous structures comprising particles and methods for making same

The present invention relates to a process for reducing malodors on fabrics using an acid delivery composition.

Process of reducing malodors on fabrics

The disclosure relates to compositions comprising a polysaccharide derivative, wherein the polysaccharide derivative comprises a polysaccharide substituted with a) at least one hydrophobic group, and b) at least one hydrophilic group, wherein the polysaccharide is poly alpha-1,3-glucan, poly alpha-1,6-glucan, or poly alpha-1,3-1,6-glucan.

Amphiphilic polysaccharide derivatives and compositions comprising same

Growing community of inventors

Mason, OH, United States of America

Mark Robert Sivik